FIELD: psychiatry. SUBSTANCE: patients are subjected to one-moment cessation of all psychotropic remedies and simultaneously immunoactive preparation Timogen 0.01% is administered intramuscularly or intranasally for 5 days in daily dose 1 ml. EFFECT: surmounted resistance to psychopharmacological therapy and enhanced treatment efficiency. 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING THE CASES OF SCHIZOPHRENIA | 2000 |
|
RU2164799C1 |
| METHOD FOR PREDICTING NEGATIVE CLINICAL MANIFESTATIONS IN SCHIZOPHRENIA FLOW | 2001 |
|
RU2188577C1 |
| METHOD FOR PREDICTING TREATMENT EFFECTIVENESS IN PATIENTS SUFFERING FROM DEPRESSIVE DISORDERS CAUSED BY SELECTIVE SEROTONINERGIC ANTIDEPRESSANTS | 2000 |
|
RU2177253C1 |
| METHOD OF CORRECTION OF PSYCHOPATHIC BEHAVIOR OF PERSONS SHOWING SCHIZOID PSYCHOPATHY | 1993 |
|
RU2094046C1 |
| AGENT STIMULATING PHAGOCYTOSIS | 1999 |
|
RU2162326C1 |
| METHOD FOR PREDICTING THE EFFICIENCY OF TREATING PATIENTS WITH SCHIZOPHRENIA WITH ATYPICAL NEUROLEPTIC QUETIAPIN (SEROQUEL) | 2005 |
|
RU2289137C1 |
| METHOD FOR PREDICTING THE EFFICIENCY OF TREATING RESIDUAL SCHIZOPHRENIA WITH ATYPICAL NEUROLEPTICS | 2006 |
|
RU2319155C2 |
| METHOD FOR TREATING PATIENTS WITH EXOGENIC-ORGANIC BRAIN LESION | 2001 |
|
RU2194489C1 |
| METHOD OF EFFICIENCY FORECAST FOR RESIDUAL SHIZOPHRENIA TREATMENT BY ATYPICAL NEUROLEPTIC QUETIAPINE | 2007 |
|
RU2349918C1 |
| METHOD OF OPHTHALMOHERPES TREATMENT ASSOCIATED WITH PROLONGED DEPRESSIONS | 2006 |
|
RU2327449C1 |
